Savant Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.4M | Sell |
3,137
-2,868
| -48% | -$1.28M | 0.01% | 677 |
|
|
2025
Q1 | $2.91M | Sell |
6,005
-645
| -10% | -$313K | 0.02% | 398 |
|
|
2024
Q4 | $2.68M | Sell |
6,650
-383
| -5% | -$154K | 0.02% | 369 |
|
|
2024
Q3 | $3.27M | Buy |
7,033
+472
| +7% | +$220K | 0.03% | 304 |
|
|
2024
Q2 | $3.08M | Buy |
6,561
+3,127
| +91% | +$1.47M | 0.03% | 280 |
|
|
2024
Q1 | $1.44M | Buy |
3,434
+763
| +29% | +$319K | 0.02% | 441 |
|
|
2023
Q4 | $1.09M | Buy |
2,671
+624
| +30% | +$254K | 0.01% | 399 |
|
|
2023
Q3 | $712K | Buy |
2,047
+62
| +3% | +$21.6K | 0.01% | 461 |
|
|
2023
Q2 | $699K | Buy |
1,985
+820
| +70% | +$289K | 0.01% | 454 |
|
|
2023
Q1 | $367K | Buy |
1,165
+244
| +26% | +$76.9K | 0.01% | 540 |
|
|
2022
Q4 | $266K | Buy |
921
+142
| +18% | +$41K | 0.01% | 495 |
|
|
2022
Q3 | $226K | Buy |
779
+50
| +7% | +$14.5K | 0.01% | 483 |
|
|
2022
Q2 | $205K | Buy |
+729
| New | +$205K | 0.01% | 525 |
|
|
2016
Q1 | – | Sell |
-2,074
| Closed | -$261K | – | 242 |
|
|
2015
Q4 | $261K | Buy |
+2,074
| New | +$261K | 0.08% | 184 |
|